Assenagon Asset Management S.A.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1546007 SENNINGERBERG, N4

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$27,427,644

+$26,378,454 QoQ

Shares Held

530,618

+1363.6% QoQ

Ownership

0.914%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Assenagon Asset Management S.A. holds $291,766,020 across 19 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	815,412	$96,389,852
2	TEVA	Teva Pharmaceutical Industries Ltd	1,339,702	$40,351,824
3	AMRX	Amneal Pharmaceuticals, Inc.	3,067,361	$38,127,297
4	UTHR	UNITED THERAPEUTICS Corp	47,183	$27,978,575
5	SUPN	Supernus Pharmaceuticals, Inc. This page	530,618	$27,427,644
6	NBIX	Neurocrine Biosciences Inc	91,478	$12,051,311
7	VTRS	Viatris Inc	783,134	$10,580,140
8	COLL	Collegium Pharmaceutical, Inc	312,598	$10,337,615

All Filings in SUPN

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,427,644	530,618	+1363.6%	Shares	Sole	2026-04-20
2023-12-31	$1,049,190	36,254	-34.0%	Shares	Sole	2024-01-17
2023-03-31	$1,988,628	54,889	-67.3%	Shares	Sole	2023-04-18
2022-12-31	$5,992,916	168,010	+298.0%	Shares	Sole	2023-01-12
2022-09-30	$1,428,977	42,215	0.0%	Shares	Sole	2022-10-27
2022-06-30	$1,220,857	42,215	-39.2%	Shares	Sole	2022-07-27
2021-12-31	$2,023,383	69,389	—	Shares	Sole	2022-02-01
No filing history on record for this holder in this stock.